Press Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Get News Alerts by Email

Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Keywords Go

Advanced Search

Search

  Search Headlines Only

From

To

Asset Types

 Video  Audio  Photos  Documents  Events  Standard

 Basic Search

• May 17, 2022

  Cardiff Oncology to Present at the H.C. Wainwright Global Investment Conference
• May 5, 2022

  Cardiff Oncology Reports First Quarter 2022 Results and Provides Business Updates
• Apr 12, 2022

  Cardiff Oncology Announces Departure of Chief Medical Officer
• Apr 8, 2022

  Cardiff Oncology Announces Data Showing the Combination of PARP Inhibition with Onvansertib Overcomes PARP Inhibitor Resistance in BRCA1-mutant and Wildtype Patient-Derived Xenograft Ovarian Cancer Models
• Apr 8, 2022

  Cardiff Oncology Announces Updated Clinical and New Biomarker Data from Phase 2 Metastatic Castration-Resistant Prostate Cancer Trial at the AACR Annual Meeting

Show 5102550100 per page